[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Pages 43547-43548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), National Center for 
Emerging and Zoonotic Infectious Diseases (NCEZID), announces the 
following meeting for the Healthcare Infection Control Practices 
Advisory Committee (HICPAC). This meeting is

[[Page 43548]]

open to the public, limited only by room seating available. The public 
is also welcome to listen to the meeting by 866-836-4010, passcode: 
18307719, and, and 100 teleconference lines are available.

DATES: The meeting will be held on November 8, 2017, 9:00 a.m. to 5:00 
p.m., EST and November 9, 2017, 9:00 a.m. to 12:00 p.m., EST.

ADDRESSES: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road 
NE., Atlanta, Georgia 30329.

FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of 
Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., 
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health 
and Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating of 
CDC guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters to be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare associated infections (HAIs), 
and DHQP's modeling efforts. It will also include updates from the 
following HICPAC workgroups: The Guideline for Prevention of Infection 
in Neonatal Intensive Care Unit (NICU) Patients; the Guideline for 
Prevention of Infection in Healthcare Personnel; the workgroup on 
updating the CDC recommendation categorization scheme; the workgroup on 
developing CDC recommendations for products and practices; and the 
National Healthcare Safety Network (NHSN) Surveillance Workgroup.
    Agenda items are subject to change as priorities dictate.
    Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt is October 25, 2017. All requests must contain the 
name, address, and organizational affiliation of the speaker, as well 
as the topic being addressed. Written comments should not exceed one 
single-spaced typed page in length and delivered in 3 minutes or less. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments. Written comments received in 
advance of the meeting will be included in the official record of the 
meeting. Registration is required to attend in person or on the phone. 
Interested parties may register at www.cdc.gov/hicpac.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-19778 Filed 9-15-17; 8:45 am]
BILLING CODE 4163-18-P